Recovery Research

KPV

KPV is a tripeptide (lysine-proline-valine) corresponding to the C-terminal fragment of α-MSH, studied for anti-inflammatory signalling in gut and immune-cell research models. Supplied lyophilised for laboratory research use only.

Read the full research profile
How it works · what studies report · scientific references
Sold out
≥99% purity target · lot-tracked
Select size
10 mg vial
€35.0010 mg vial
Ships from IrelandTracked
Dispatched in 1–2 working daysTracked, EU dispatch
Lost in transit?Replacement first
Real supportWhatsApp & email
Plain outer packaging, no product names or branding on the parcel. Questions? WhatsApp us
Currently sold out — join the Insiders list below for the restock notice.
Why does the vial look empty?
That’s normal. The peptide is supplied lyophilised (freeze-dried) — often a thin film or a few milligrams at the base of the vial, easy to mistake for empty. It’s all there; reconstitute with bacteriostatic water before use.
Research handling note
Reconstitute with bacteriostatic water and store the lyophilised vial at −20 °C until use; once reconstituted, refrigerate and use within the documented window. For laboratory research purposes only — not for human consumption, diagnostic, or therapeutic use. Need to work out your dilution? Use the reconstitution calculator
Recovery Research

KPV — research profile

For research purposes only — not for human consumption

KPV is a tripeptide — lysine-proline-valine — corresponding to the C-terminal fragment (residues 11–13) of the hormone α-melanocyte-stimulating hormone (α-MSH). Despite its small size it retains much of α-MSH’s reported anti-inflammatory activity, which is the focus of research interest.

Research models report that KPV is taken up into cells via the PepT1 transporter and down-regulates pro-inflammatory NF-κB signalling, with particular attention to intestinal and immune-cell inflammation.

How it’s studied

  • PepT1 uptake: transporter-mediated entry into intestinal and immune cells.
  • NF-κB signalling: down-regulation of pro-inflammatory transcription.
  • Gut inflammation: colitis and mucosal-inflammation models.
  • Immune modulation: α-MSH-linked anti-inflammatory pathways.

Areas under investigation

AreaReported research focus
Intestinal inflammationPepT1-mediated anti-inflammatory action.
Immune signallingNF-κB and cytokine pathways.
Skin & wound modelsα-MSH-derived tissue signalling.

References

  1. Dalmasso G, et al. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166–178.

Specifications

SpecificationDetail
ProductKPV
FormatLyophilised vial
Fill10 mg per vial
Molecular formulaC16H30N4O4
PuritySpecified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes
Price€35.00
AvailabilityCurrently sold out — restock in progress. Join the Insiders list for the restock notice.
Supplied forLaboratory research use only — not for human consumption, diagnostic or therapeutic use
Verifiability

Batch Testing & COA

Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.

How to verify a COA and its SHA-256 checksum →

Insiders

First access: new batches, restocks and the lab tools.

Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.